# Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity

> **NCT03378960** · PHASE4 · COMPLETED · sponsor: **Emilio Vargas Castrillón** · enrollment: 43 (actual)

## Conditions studied

- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Omeprazole 20mg

## Key facts

- **NCT ID:** NCT03378960
- **Lead sponsor:** Emilio Vargas Castrillón
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-31
- **Primary completion:** 2015-12-23
- **Final completion:** 2016-02-29
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378960, "Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03378960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*